Mutations in RAD51C and XRCC2 are associated with Fanconi Anemia, which causes bone marrow failure and a predisposition to leukemia and solid tumors, and mutations in all RAD51 paralogs have been associated with multiple types of cancer including mostly breast and ovarian cancers [4,14,17]. This evidence concerns the gene RAD51 and Fanconi anemia.